ACT Advisors, LLC.
- SEC CIK
- 0001842554
- Latest filing
- Jul 22, 2026
HRTX holding history
Heron Therapeutics, Inc. in every 13F filed by ACT Advisors, LLC., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HRTX overviewAll 13F holders of HRTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −28,443−100.0% | Sold out | Holders |
| Q1 2026 | 28,443 | $22.8K | <0.1% | +2,635+10.2% | Added | Holders |
| Q4 2025 | 25,808 | $33.5K | <0.1% | +227+0.9% | Added | Holders |
| Q3 2025 | 25,581 | $32.2K | <0.1% | −74−0.3% | Reduced | Holders |
| Q2 2025 | 25,655 | $53.1K | <0.1% | +74+0.3% | Added | Holders |
| Q1 2025 | 25,581 | $56.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 25,581 | $39.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 25,581 | $50.9K | <0.1% | +3,436+15.5% | Added | Holders |
| Q2 2024 | 22,145 | $77.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 22,145 | $61.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 22,145 | $37.6K | <0.1% | +22,145 | New | Holders |